More News

11 Sep 2007 Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
11 Sep 2007 Antobody Engineering Company F-Star Raises EUR 6.0 million in Series A Financing From Aescap Venture and Atlas Venture
11 Sep 2007 GenVec to Develop New Malaria Vaccine for the U.S Military
11 Sep 2007 Mylan Announces Tentative FDA Approval for Topiramate Capsules
08 Sep 2007 Isis and Alnylam Launch Regulus Therapeutics, a Joint Venture to Discover, Develop, and Commercialize microRNA Therapeutics
08 Sep 2007 Ablynx and Boehringer Ingelheim announce major global strategic alliance to discover, develop and commercialise novel nanobody(R) therapeutics
08 Sep 2007 Penwest Enters Into Research and Development Agreement With Otsuka Pharmaceutical
08 Sep 2007 Penwest Enters Into Research and Development Agreement With Otsuka Pharmaceutical
07 Sep 2007 Teva Announces Approval And Shipment Of Generic Coreg(R) Tablets
07 Sep 2007 Ranbaxy gains US FDA approval to manufacture and market Carvedilol Tablets in the US market
07 Sep 2007 Mylan Announces Final FDA Approval for Carvedilol Tablets
07 Sep 2007 Theravance Retains Full Ownership of Gastrointestinal Motility Dysfunction Program and TD-1792 Antibiotic
06 Sep 2007 Lundbeck and Takeda form Alliance to Develop and Commercialize a Portfolio of Novel Compounds in the US and Japan for the Treatment of Mood and Anxiety Disorders
06 Sep 2007 Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
06 Sep 2007 Dyax Corp. and Bayer Schering Pharma AG Enter Into a Collaboration Agreement for Discovery of Therapeutic Antibodies
06 Sep 2007 PLIVA Enters Oncology Business in Germany
06 Sep 2007 Meda acquires exclusive rights to potential specialty blockbuster product in the US
06 Sep 2007 Eisai Inc. Enters Copromotion Agreement with Salix Pharmaceuticals, Ltd. for Balsalazide Products
06 Sep 2007 Eisai Inc. Enters Copromotion Agreement with Salix Pharmaceuticals, Ltd. for Balsalazide Products
06 Sep 2007 AKELA Pharma Inc. announces positive results for the extension part of its Phase IIB Fentanyl TAIFUN(R) Trial
06 Sep 2007 Pieris validates the use of Anticalins(R) as ophthalmologic biotherapeutics
06 Sep 2007 Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
06 Sep 2007 FDA Approves First Generic Versions of Coreg
04 Sep 2007 Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
04 Sep 2007 Jerini Regains Commercialization Rights to Icatibant for the Treatment of Hereditary Angioedema in North America

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top